Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 3
1980 3
1981 9
1982 11
1983 51
1984 26
1985 28
1986 27
1987 18
1988 24
1989 21
1990 37
1991 32
1992 25
1993 33
1994 41
1995 39
1996 26
1997 29
1998 75
1999 82
2000 102
2001 162
2002 182
2003 177
2004 210
2005 238
2006 226
2007 248
2008 280
2009 264
2010 257
2011 270
2012 277
2013 287
2014 254
2015 271
2016 302
2017 239
2018 246
2019 228
2020 249
2021 242
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

5,323 results
Results by year
Filters applied: . Clear all
Page 1
Bupropion Hydrochloride.
Khan SR, Berendt RT, Ellison CD, Ciavarella AB, Asafu-Adjaye E, Khan MA, Faustino PJ. Khan SR, et al. Profiles Drug Subst Excip Relat Methodol. 2016;41:1-30. doi: 10.1016/bs.podrm.2015.12.001. Epub 2016 Feb 17. Profiles Drug Subst Excip Relat Methodol. 2016. PMID: 26940167 Review.
Bupropion hydrochloride is a norepinephrine-dopamine disinhibitor (NDDI) approved for the treatment of depression and smoking cessation. Bupropion is a trimethylated monocyclic phenylaminoketone second-generation antidepressant, which differs structurally from most
Bupropion hydrochloride is a norepinephrine-dopamine disinhibitor (NDDI) approved for the treatment of depression and smoking cessati
Use of bupropion in combination with serotonin reuptake inhibitors.
Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB. Zisook S, et al. Biol Psychiatry. 2006 Feb 1;59(3):203-10. doi: 10.1016/j.biopsych.2005.06.027. Epub 2005 Sep 13. Biol Psychiatry. 2006. PMID: 16165100 Review.
This article reviews the literature on combining bupropion with SSRIs or SNRIs. We used MEDLINE to select studies that included patients diagnosed with MDD treated with any combination of bupropion and an SSRI or SNRI, either to enhance antidepressant response or to …
This article reviews the literature on combining bupropion with SSRIs or SNRIs. We used MEDLINE to select studies that included patie …
Naltrexone/bupropion for obesity.
[No authors listed] [No authors listed] Drug Ther Bull. 2017 Nov;55(11):126-129. doi: 10.1136/dtb.2017.11.0550. Drug Ther Bull. 2017. PMID: 29117992 Review.
Naltrexone/bupropion (Mysimba - Orexigen Therapeutics Ireland Limited) is a fixed-dose combination product for the treatment of adults who are obese or overweight with at least one weight-related comorbidity, as an adjunct to diet and lifestyle modifications. ...
Naltrexone/bupropion (Mysimba - Orexigen Therapeutics Ireland Limited) is a fixed-dose combination product for the treatment of adult …
Bupropion Use During Pregnancy: A Systematic Review.
Hendrick V, Suri R, Gitlin MJ, Ortiz-Portillo E. Hendrick V, et al. Prim Care Companion CNS Disord. 2017 Sep 21;19(5):17r02160. doi: 10.4088/PCC.17r02160. Prim Care Companion CNS Disord. 2017. PMID: 28973846 Free article. Review.
The following keywords were used: bupropion, pregnancy, depression, smoking cessation, birth outcomes, miscarriage, and spontaneous abortion. ...A total of 8 studies were included in this review. RESULTS: Bupropion's use in the first trimester has been linked …
The following keywords were used: bupropion, pregnancy, depression, smoking cessation, birth outcomes, miscarriage, and spontaneous a …
Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.
Costa R, Oliveira NG, Dinis-Oliveira RJ. Costa R, et al. Drug Metab Rev. 2019 Aug;51(3):293-313. doi: 10.1080/03602532.2019.1620763. Epub 2019 Jun 14. Drug Metab Rev. 2019. PMID: 31124380 Review.
Bupropion is a chiral, basic, highly lipophilic drug, clinically used as racemate that undergoes extensive stereoselective metabolism. Its major active metabolites, hydroxybupropion, threohydrobupropion, and erythrohydrobupropion reach higher plasma concentrations than
Bupropion is a chiral, basic, highly lipophilic drug, clinically used as racemate that undergoes extensive stereoselective metabolism
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C. Verbeeck W, et al. Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2. Cochrane Database Syst Rev. 2017. PMID: 28965364 Free PMC article. Review.
AUTHORS' CONCLUSIONS: The findings of this review, which compared bupropion to placebo for adult ADHD, indicate a possible benefit of bupropion. ...Furthermore, we found low-quality evidence that the tolerability of bupropion is similar to that of placebo. In …
AUTHORS' CONCLUSIONS: The findings of this review, which compared bupropion to placebo for adult ADHD, indicate a possible benefit of …
Antidepressant-Induced Hyponatremia in Older Adults.
Viramontes TS, Truong H, Linnebur SA. Viramontes TS, et al. Consult Pharm. 2016 Mar;31(3):139-50. doi: 10.4140/TCP.n.2016.139. Consult Pharm. 2016. PMID: 26975593 Review.
Selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors, and mirtazapine were implicated in the majority of the case reports and clinical studies evaluating older adults. Bupropion, trazodone, and tricyclic antidepressants were implicated less …
Selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors, and mirtazapine were implicated in the majority of th …
A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
Ng QX. Ng QX. J Child Adolesc Psychopharmacol. 2017 Mar;27(2):112-116. doi: 10.1089/cap.2016.0124. Epub 2016 Nov 4. J Child Adolesc Psychopharmacol. 2017. PMID: 27813651 Review.
RESULTS: All available open, controlled, and randomized trials demonstrated bupropion's efficacy in improving ADHD symptoms. The three head-to-head trials found that bupropion had efficacy comparable to methylphenidate (p > 0.05). However, a large double-b …
RESULTS: All available open, controlled, and randomized trials demonstrated bupropion's efficacy in improving ADHD symptoms. T …
Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity.
Stahl SM. Stahl SM. CNS Spectr. 2019 Oct;24(5):461-466. doi: 10.1017/S1092852919001470. CNS Spectr. 2019. PMID: 31566163 Review.
The recent approval of the NMDA (N-methyl-d-aspartate) antagonist esketamine given intranasally for treatment-resistant depression has reinforced the need for agents with rapid onset with alternate mechanisms of action. Dextromethorphan/bupropion, an investigational medici …
The recent approval of the NMDA (N-methyl-d-aspartate) antagonist esketamine given intranasally for treatment-resistant depression has reinf …
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.
Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin MN, Fathi J, Fennig K, Folan P, Galiatsatos P, Gogineni H, Kantrow S, Kathuria H, Lamphere T, Neptune E, Pacheco MC, Pakhale S, Prezant D, Sachs DPL, Toll B, Upson D, Xiao D, Cruz-Lopes L, Fulone I, Murray RL, O'Brien KK, Pavalagantharajah S, Ross S, Zhang Y, Zhu M, Farber HJ. Leone FT, et al. Am J Respir Crit Care Med. 2020 Jul 15;202(2):e5-e31. doi: 10.1164/rccm.202005-1982ST. Am J Respir Crit Care Med. 2020. PMID: 32663106 Free PMC article.
Strong recommendations include using varenicline rather than a nicotine patch, using varenicline rather than bupropion, using varenicline rather than a nicotine patch in adults with a comorbid psychiatric condition, initiating varenicline in adults even if they are unready …
Strong recommendations include using varenicline rather than a nicotine patch, using varenicline rather than bupropion, using varenic …
5,323 results